Srikanth Ranganathan, Ph.D. - Publications

University of Pittsburgh, Pittsburgh, PA, United States 
molecular and cellular basis of neurodegenerative diseases

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Zhang H, Petit GH, Gaughwin PM, Hansen C, Ranganathan S, Zuo X, Smith R, Roybon L, Brundin P, Mobley WC, Li JY. NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease. Journal of Huntington's Disease. 2: 69-82. PMID 25063430 DOI: 10.3233/JHD-120026  0.44
2011 Duarte AI, Petit GH, Ranganathan S, Li JY, Oliveira CR, Brundin P, Björkqvist M, Rego AC. IGF-1 protects against diabetic features in an in vivo model of Huntington's disease. Experimental Neurology. 231: 314-9. PMID 21763311 DOI: 10.1016/j.expneurol.2011.06.016  0.44
2010 Ranganathan S, Bowser R. p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALS. The Open Pathology Journal. 4: 11-22. PMID 21572928 DOI: 10.2174/1874375701004010011  0.44
2010 Ranganathan S, Fischbeck KH. Therapeutic approaches to spinal and bulbar muscular atrophy. Trends in Pharmacological Sciences. 31: 523-7. PMID 20863580 DOI: 10.1016/  0.44
2009 Ranganathan S, Harmison GG, Meyertholen K, Pennuto M, Burnett BG, Fischbeck KH. Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Human Molecular Genetics. 18: 27-42. PMID 18824496 DOI: 10.1093/hmg/ddn310  0.44
2008 Burnett BG, Andrews J, Ranganathan S, Fischbeck KH, Di Prospero NA. Expression of expanded polyglutamine targets profilin for degradation and alters actin dynamics. Neurobiology of Disease. 30: 365-74. PMID 18417352 DOI: 10.1016/j.nbd.2008.02.007  0.44
2007 Ranganathan S, Nicholl GC, Henry S, Lutka F, Sathanoori R, Lacomis D, Bowser R. Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 8: 373-9. PMID 17852009 DOI: 10.1080/17482960701549681  0.44
2006 Ranganathan S, Polshyna A, Nicholl G, Lyons-Weiler J, Bowser R. Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling. Clinical Proteomics. 2: 91-101. PMID 20200596 DOI: 10.1385/CP:2:1:91  0.44
2006 Levy JR, Sumner CJ, Caviston JP, Tokito MK, Ranganathan S, Ligon LA, Wallace KE, LaMonte BH, Harmison GG, Puls I, Fischbeck KH, Holzbaur EL. A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation. The Journal of Cell Biology. 172: 733-45. PMID 16505168 DOI: 10.1083/jcb.200511068  0.44
2006 Gopalakrishnan V, Ganchev P, Ranganathan S, Bowser R. Rule learning for disease-specific biomarker discovery from clinical proteomic mass spectra Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 3916: 93-105.  0.44
2005 Ranganathan S, Williams E, Ganchev P, Gopalakrishnan V, Lacomis D, Urbinelli L, Newhall K, Cudkowicz ME, Brown RH, Bowser R. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. Journal of Neurochemistry. 95: 1461-71. PMID 16313519 DOI: 10.1111/j.1471-4159.2005.03478.x  0.44
2003 Ranganathan S, Bowser R. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. The American Journal of Pathology. 162: 823-35. PMID 12598317 DOI: 10.1016/S0002-9440(10)63879-5  0.44
2002 Ranganathan S, Bowser R. The 12th International Symposium on ALS/MND: scientific advancements in amyotrophic lateral sclerosis. November 18-20, 2001, Oakland, Calif. Brain Pathology (Zurich, Switzerland). 12: 511-4. PMID 12408238  0.44
2001 Ranganathan S, Scudiere S, Bowser R. Hyperphosphorylation of the retinoblastoma gene product and altered subcellular distribution of E2F-1 during Alzheimer's disease and amyotrophic lateral sclerosis. Journal of Alzheimer's Disease : Jad. 3: 377-385. PMID 12214040  0.44
2001 Abounader R, Ranganathan S, Kim BYS, Nichols C, Laterra J. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma Journal of Neurochemistry. 76: 1497-1508. PMID 11238734 DOI: 10.1046/j.1471-4159.2001.00158.x  0.44
1999 Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P, Laterra J. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression Journal of the National Cancer Institute. 91: 1548-1556. PMID 10491431  0.44
1999 Book AA, Ranganathan S, Abounader R, Rosen E, Laterra J. Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability Brain Research. 833: 173-180. PMID 10375692 DOI: 10.1016/S0006-8993(99)01527-9  0.44
1997 Laterra J, Rosen E, Nam M, Ranganathan S, Fielding K, Johnston P. Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth Biochemical and Biophysical Research Communications. 235: 743-747. PMID 9207232 DOI: 10.1006/bbrc.1997.6853  0.44
Show low-probability matches.